Brian Berry

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

Laurie H. Sehn, Brian Berry, Mukesh Chhanabhai et al. · Blood · 2006 · 1.5K citations

Medicine, Hematology, Oncology +5

Impact of Concordant and Discordant Bone Marrow Involvement on Outcome in Diffuse Large B-Cell Lymphoma Treated With R-CHOP

Laurie H. Sehn, David W. Scott, Mukesh Chhanabhai et al. · Journal of Clinical Oncology · 2011 · 232 citations · Full text

Medicine, Hematology, Oncology +14

Organochlorines and risk of non‐Hodgkin lymphoma

John J. Spinelli, Carmen Ng, Jean‐Philippe Weber et al. · International Journal of Cancer · 2007 · 132 citations

Pharmacy, Environmental Sciences, Toxicology +13

CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma

Kenneth S. Wilson, Laurie H. Sehn, Brian Berry et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2007 · 68 citations

Medicine, Hematology, Oncology +13

Blastic Mantle Cell Leukemia: An Unusual Presentation of Blastic Mantle Cell Lymphoma

David S. Viswanatha, Kathryn Foucar, Brian Berry et al. · Modern Pathology · 2000 · 58 citations · Full text

Medicine, Hematology, Oncology +13